a home grown opportunity

Sequence Bio is a Newfoundland and Labrador biotechnology company striving to improve how we treat diseases and develop medicines.

We're getting going. Read all about our NEW research pilot project.
New Brunswick Genome Project

this Pilot is ready for takeoff

Sequence Bio is launching its first genomics research project this fall in Atlantic Canada to research the genetic makeup of 2,500 volunteering participants in New Brunswick.

By designing one of a kind research studies, we're on our way to better understanding unique genetic populations and discovering better, safer treatments for the diseases that impact us the most.

click here to learn more

Sequence Bio

Can we improve healthcare and drug discovery here at home?

It is our goal to launch the NL Genome Project, a community-based initiative enabling innovative science, in Newfoundland and Labrador.


there's nowhere quite like it

Modern drug discovery relies on the right kind of information: real-world patient data that integrates pan-omics with well-characterized phenotypic information. And while this information isn't found everywhere, it is found in Newfoundland and Labrador.

Icon isolated

unique isolated population

Icon desease

high incidence of rare and complex diseases

Icon electronic records

comprehensive electronic health records

Icon family

extended family pedigrees


a life-changing approach

We're always looking for exciting partnerships with companies that understand the value of human genetics as a platform for drug discovery and are willing to share our commitment to the people of Newfoundland and Labrador, so get in touch today!

inquire about partnerships

Our Partners

meet the team

We're a happy mix from all across Newfoundland and Labrador, with a higher than average affinity for ping-pong. Our kitchen always has some fresh Tetley on the boil and Jam Jam cookies in the cupboard. Get to know us a little more by clicking on our lovely mugs!

We're hiring, join the team

Chris Gardner

ceo & president

jeremy grushcow PhD JD

chief business officer

Michael S. Phillips PhD

Chief scientific officer

Gerry Mugford PhD

Director of research

Sophie Harrington

vp, marketing & strategy

Dan Brake

vp, engineering & information security

Neala Quigley

director of community engagement

Fanny Coron

genetic counsellor

Dave Phillips

director of finance

Matt Stenback

director of application development


chief indifference officer


scientific advisory board

Dr. Kathy Hudson

people-centered research foundation

Dr. Euan Ashley

Stanford medicine

Dr. Pek Lum

auransa inc.


board of directors

Chris Gardner

sequence bio

Mark Dobbin

killick capital

Dr. Andrew Furey

Team broken earth

James Hardiman


Sequence Bio is planning to conduct research in Newfoundland and Labrador, and doing so in an ethical and transparent way is our first priority. Our research efforts require approval by the Health Research Ethics Board (HREB). The words “believe,” “expect,” “anticipate,” and similar expressions, among others, generally identify our intent and/or objective to undertake research in this province and may be subject to change after HREB Review, and will continue to evolve as our business grows.

Therefore, to ensure full compliance with the process, Sequence Bio will not be sharing any information about planned research studies until approved.